Filing Details
- Accession Number:
- 0001209191-12-019455
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-21 19:08:57
- Reporting Period:
- 2012-03-19
- Filing Date:
- 2012-03-21
- Accepted Time:
- 2012-03-21 19:08:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1411861 | Mako Surgical Corp. | MAKO | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 201901148 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1433586 | H Duncan Moffat | C/O Mako Surgical Corp. 2555 Davie Road Ft. Lauderdale FL 33317 | Svp Of Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-03-19 | 15,918 | $7.94 | 33,825 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-03-19 | 778 | $8.06 | 34,603 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-03-19 | 16,696 | $40.17 | 17,907 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2012-03-19 | 15,918 | $0.00 | 15,918 | $7.94 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2012-03-19 | 778 | $0.00 | 778 | $8.06 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,770 | 2018-04-28 | No | 4 | M | Direct | |
| 31,722 | 2019-02-20 | No | 4 | M | Direct |
Footnotes
- The exercise and sales reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2011.
- The price in column 4 is a weighted average price per share. The prices actually paid ranged from $40.00 to $41.30 per share. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- Vests and becomes exercisable ratably quarterly over four years commencing on the grant date.
Billionaire Hedge Funds
